Blaise is co-founder of CureMatch. He is a serial entrepreneur with a 30-year track record in building successful technology companies, and is a recognized trailblazer in the big data sectors.

Blaise has a passion for developing innovative solutions that empower organizations to make data-driven business decisions. In the mid 1990s, he founded WebSideStory, the Web analytics industry pioneer who had a successful IPO in 2004.

A board-certified medical oncologist and a renowned expert in precision medicine, Dr. Kurzrock is known for developing one of the largest and best known Phase I clinical trial programs in the United States while at MD Anderson Cancer Center in Texas. She is currently heading UCSD’s newly established Center for Personalized Cancer Therapy at the Moores Cancer Center.

With over fifteen years of international business development experience, Stephane brings to CureMatch his experience of the biotech industry, strategy, management and an exceptional network of collaborators.

Igor originally developed the CureMatch technology while serving as Research Professor at the Department of Neurosciences, San Diego Supercomputer Center, and Moore’s Cancer Center (MCC). He is a member of the Molecular Tumor Board of the MCC, and is a recognized expert in molecular mechanisms of disease, structural biology, molecular modeling, bioinformatics and structure-based drug design.

Philippe has a background in software engineering and executive management of small to mid- size companies, where he has worked closely with the business and scientific teams to design complex software products such that they are optimized and productizable. He has led several start-up ventures at the CEO and COO level in the wireless and medical devices areas.

Gilles brings nearly 20 years of finance, administration, and human resources management experience to CureMatch. He holds an MBA from Université Paris IX Dauphine, one the leading European universities for finance and business management.